GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Synonyms: DS-6000 | DS-6000A | R-DXd
Compound class:
Antibody
Comment: Raludotatug deruxtecan (R-DXd; DS-6000a) is an anti-CDH6 monoclonal conjugated to the chemotherapy agent deruxtecan (DXd; a derivative of the topoisomerase I inhibitor exatecan) [1-2]. The antitumour effect of raludotatug deruxtecan is due to intracellular release of the toxic payload; the naked antibody has no anti-tumour activity.
|
Classification ![]() |
|
| Compound class | Antibody |
International Nonproprietary Names ![]() |
|
| INN number | INN |
| 12314 | raludotatug deruxtecan |
Synonyms ![]() |
| DS-6000 | DS-6000A | R-DXd |
Database Links ![]() |
|
| Specialist databases | |
| IMGT/mAb-DB | 1350 |
| Other databases | |
| Search PubMed clinical trials | raludotatug deruxtecan |
| Search PubMed titles | raludotatug deruxtecan |
| Search PubMed titles/abstracts | raludotatug deruxtecan |